En Es
Categories

Agena Bioscience

Agena Bioscience is dedicated to advancing the impact of genomics in healthcare and precision medicine with a mission is to equip genomic and clinical testing laboratories with practical solutions that increase productivity and decrease time to results. Whether assessing sample quality, screening samples for actionabl ...
Products Covid-19NewsSummary
Close

Covid-19 Agena Bioscience

Clinical Laboratory

SARS-CoV-2 Variant Panel (RUO)
MassARRAY SARS-CoV-2 Variant Panel (RUO)

The MassARRAY SARS-CoV-2 Variant Panel (RUO) is intended for the detection of key SARS-CoV-2 virus strains, including the UK (B.1.1.7), South Africa (B.1.351), Brazil (P.1) and Denmark (Cluster 5) variants. The high throughput, low-cost and rapid panel sets for the detection and discrimination of the dominant SARS-CoV-2 variants are available in both 96 and 384 reaction formats to support varying sample throughput.
More details

Mass Spectrometer
MassARRAY System

The MassARRAY System workflow couples mass spectrometry with end-point PCR, enabling highly multiplexed reactions under universal cycling conditions to provide accurate, sensitive and rapid genetic analysis. Available in 96 and 384-well plate formats, the open platform can grow with the lab and simplify the genetic testing process with easy-to-interpret data, fast turn-around times, and broad genetic coverage.
More details

SARS-CoV-2/Flu RT-PCR Test (RUO)
MassARRAY SARS-CoV-2/Flu Panel (RUO)

The MassARRAY SARS-CoV-2/Flu Panel (RUO) is a multiplex RT-PCR test that simultaneously detects and differentiates between SARS-CoV-2 and Influenza A/B viral RNA from a single sample. It consolidates key SARS-CoV-2 target assays for built-in redundancy. Each assay targets highly conserved regions to ensure accurate detection.
More details

SARS-CoV-2 Assay
MassARRAY SARS-CoV-2 Panel

The MassARRAY SARS-CoV-2 Panel is a high-throughput and low-cost assay designed for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens and bronchoalveolar lavage (BAL) from individuals suspected of COVID-19 by their healthcare provider. The assay for in vitro diagnostic use has received FDA Emergency Use Authorization (EUA) and is CE-IVD marked for in vitro diagnostic use in Europe.
More details

Multiplex Genetic Analyzer
MassARRAY Dx Analyzer

The MassARRAY Dx Analyzer is a benchtop multiplex genetic analyzer that simplifies the complex clinical genetics environment with easy-to-interpret data, flexible biomarker detection and robust performance. Placed at the center of the clinical workflow, labs can optimize throughput, turn-around-times, and data analysis. As their need for marker coverage expands, labs will be empowered to provide targeted patient diagnostics more quickly, which ultimately leads to faster treatment decisions.
More details
Close

News of Agena Bioscience

Mesa Laboratories to Acquire Molecular Diagnostics Tools Company Agena Bioscience

15 Sep 2021
Mesa Laboratories to Acquire Molecular Diagnostics Tools Company Agena Bioscience
Mesa Laboratories, Inc. (Lakewood, CO, USA) has entered into a definitive agreement to acquire Agena Bioscience, Inc. (San Diego, CA, USA).
Read More
Close

About Agena Bioscience

Agena Bioscience is dedicated to advancing the impact of genomics in healthcare and precision medicine with a mission is to equip genomic and clinical testing laboratories with practical solutions that increase productivity and decrease time to results. Whether assessing sample quality, screening samples for actionable mutations, or enabling routine genetic testing for tens to thousands of samples, the company’s products and services help laboratories translate genomic discoveries into mainstream clinical practice.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 Variant Panel (RUO)

SARS-CoV-2 Variant Panel (RUO)

Model: MassARRAY SARS-CoV-2 Variant Panel (RUO)
Request Information

Description:

The MassARRAY SARS-CoV-2 Variant Panel (RUO) is intended for the detection of key SARS-CoV-2 virus strains, including the UK (B.1.1.7), South Africa (B.1.351), Brazil (P.1) and Denmark (Cluster 5) variants. The high throughput, low-cost and rapid panel sets for the detection and discrimination of the dominant SARS-CoV-2 variants are available in both 96 and 384 reaction formats to support varying sample throughput.

Features

Features

• GET ACCURATE DETECTION: Detect and differentiate 12 unique SARS-CoV-2 variants from the Wuhan lineage of SARS-CoV-2.
• MAXIMIZE THROUGHPUT: Process up to hundreds or thousands of samples on a single instrument in a single workday.
• SIMPLIFY INTERPRETATION: Clear identification of variants of concern without the need for extensive bioinformatics analysis.
• SAVE TIME & MONEY: Low-cost reagents and automated results reporting save lab resources. Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Agena Bioscience (SARS-CoV-2 Variant Panel (RUO))
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions